Al Franco, M.D.
NPI 1528128535 · Rheumatology Physician · Riverside, CA
Provider details
- NPI number
- 1528128535
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- A35128 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
63,303 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Measurement of Antibody for Assessment of Autoimmune Disorder, Any Method86235 | 6,456 | $18 |
| Gammaglobulin (immune System Protein) Measurement82784 | 2,481 | $9 |
| Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement86146 | 2,469 | $25 |
| Phospholipid Antibody (autoimmune Antibody) Measurement86148 | 2,463 | $16 |
| Cardiolipin Antibody (tissue Antibody) Measurement86147 | 2,460 | $25 |
| Analysis of Substance Using Immunoassay Technique, Multiple Step Method83516 | 1,838 | $11 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,013 across 44 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-12-11
- Last updated
- 2015-03-04
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.